Corpometria Institute Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2020
NCT04729491
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Corpometria Institute | Corpometria Institute; Applied Biology

Indications

Overview

  • Highest Phase: Phase 3
  • # of Trials: 5
  • # of Trial APIs: 6